Exclusion Criteria:~1. Any medical or neurological/neurodegenerative condition (other than AD) that, in the
opinion of the Investigator, might be a contributing cause to the participant's cognitive impairment (e.g.,
current history of substance abuse, uncontrolled vitamin B12 deficiency or abnormal thyroid function, stroke or
other cerebrovascular condition, normal pressure hydrocephalus, Parkinson's Disease, Lewy body dementia,
cerebral amyloid angiopathy, frontotemporal dementia) or could lead to discontinuation, lack of compliance,
interference with study assessments, or safety concerns.~2. Non-amnestic presentation of AD as judged by the
investigator.~3. Woman of childbearing potential.~4. Any prior or ongoing exposure to active or passive
anti-amyloid immunotherapy, anti-tau immunotherapy, an anti-tau antisense oligonucleotide or gene therapy, or
O-linked-Î²-N-acetylglucosaminidase (O-GlcNAcase) inhibitor.~Other protocol defined inclusion and exclusion
criteria could apply.
